Search Results - "Scherstén, Fredrik"

Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden by James, Stefan K, Stenestrand, Ulf, Lindbäck, Johan, Carlsson, Jörg, Scherstén, Fredrik, Nilsson, Tage, Wallentin, Lars, Lagerqvist, Bo

“…In this study from a large Swedish registry, the long-term risk of death or myocardial infarction was similar among patients who received bare-metal coronary…”
Get full text

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction by Erlinge, David, Omerovic, Elmir, Fröbert, Ole, Linder, Rikard, Danielewicz, Mikael, Hamid, Mehmet, Swahn, Eva, Henareh, Loghman, Wagner, Henrik, Hårdhammar, Peter, Sjögren, Iwar, Stewart, Jason, Grimfjärd, Per, Jensen, Jens, Aasa, Mikael, Robertsson, Lotta, Lindroos, Pontus, Haupt, Jan, Wikström, Helena, Ulvenstam, Anders, Bhiladvala, Pallonji, Lindvall, Bo, Lundin, Anders, Tödt, Tim, Ioanes, Dan, Råmunddal, Truls, Kellerth, Thomas, Zagozdzon, Leszek, Götberg, Matthias, Andersson, Jonas, Angerås, Oskar, Östlund, Ollie, Lagerqvist, Bo, Held, Claes, Wallentin, Lars, Scherstén, Fredrik, Eriksson, Peter, Koul, Sasha, James, Stefan

“…Patients undergoing PCI for acute myocardial infarction were randomly assigned to heparin or bivalirudin anticoagulation. There was no significant difference…”
Get full text

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic by Mohammad, Moman A, Koul, Sasha, Olivecrona, Göran K, Gӧtberg, Matthias, Tydén, Patrik, Rydberg, Erik, Scherstén, Fredrik, Alfredsson, Joakim, Vasko, Peter, Omerovic, Elmir, Angerås, Oskar, Fröbert, Ole, Calais, Fredrik, Völz, Sebastian, Ulvenstam, Anders, Venetsanos, Dimitrios, Yndigegn, Troels, Oldgren, Jonas, Sarno, Giovanna, Grimfjärd, Per, Persson, Jonas, Witt, Nils, Ostenfeld, Ellen, Lindahl, Bertil, James, Stefan K, Erlinge, David

“…Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited…”
Get more information

Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock by Gjesdal, Grunde, Braun, Oscar Ö, Smith, J Gustav, Scherstén, Fredrik, Tydén, Patrik

“…Mortality in patients with acute myocardial infarction (AMI) has improved substantially with modern therapy including percutaneous coronary interventions (PCI)…”
Get full text

Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction by Mohammad, Moman A., Andell, Pontus, Koul, Sasha, James, Stefan, Scherstén, Fredrik, Götberg, Matthias, Erlinge, David

“…Patients pretreated with ticagrelor with less than 1 hour from percutaneous coronary intervention (PCI) or receiving ticagrelor in cath lab were prospectively…”
Get full text

Tailored nurse-led cardiac rehabilitation after myocardial infarction results in better risk factor control at one year compared to traditional care: a retrospective observational study by Ögmundsdottir Michelsen, Halldora, Nilsson, Marie, Scherstén, Fredrik, Sjölin, Ingela, Schiopu, Alexandru, Leosdottir, Margret

“…Cardiac rehabilitation improves prognosis after an acute myocardial infarction (AMI), however, the optimal method of implementation is unknown. The aim of the…”
Get full text

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention by Koul, Sasha, Smith, J Gustav, Scherstén, Fredrik, James, Stefan, Lagerqvist, Bo, Erlinge, David

“…AIMS Immediate treatment with a loading dose of clopidogrel at diagnosis of ST-segment elevation myocardial infarction (STEMI) is recommended by ESC/AHA/ACC…”
Get full text

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score by GUSTAV SMITH, J, WIELOCH, Mattias, KOUL, Sasha, BRAUN, Oscar Ö, LUMSDEN, Jonathan, RYDELL, Emil, ÖHMAN, Jenny, SCHERSTEN, Fredrik, SVENSSON, Peter J, VAN DER PALS, Jesper

“…The aim of this study was to evaluate the prevalence of triple antithrombotic therapy (TT) (warfarin, aspirin and clopidogrel) in patients following an acute…”
Get full text

Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry by Lagerqvist, Bo, Carlsson, Jörg, Fröbert, Ole, Lindbäck, Johan, Scherstén, Fredrik, Stenestrand, Ulf, James, Stefan K

“…BACKGROUND—The objective was to evaluate the role of risk factors and stent type for stent thrombosis (ST) using a large real world registry. METHODS AND…”
Get full text

Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy by Bergman, Sofia, Mohammad, Moman A, James, Stefan K, Angerås, Oskar, Wagner, Henrik, Jensen, Jens, Scherstén, Fredrik, Fröbert, Ole, Koul, Sasha, Erlinge, David

“…Background The clinical importance of intraprocedural stent thrombosis (IPST) during percutaneous coronary intervention in the contemporary era of potent oral…”
Get full text

Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction - a registry-based randomized clinical trial (RRCT) in the SWEDEHEART registry (the VALIDATE-SWEDEHEART-trial) by Erlinge, David, Koul, Sasha, Eriksson, Peter, Scherstén, Fredrik, Omerovic, Elmir, Linder, Rikard, Östlund, Olof Petter, Wallentin, Lars, Fröbert, Ole, James, Stefan

“…Abstract Background The optimal anti-coagulant for patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) has not…”
Get full text

Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome by Braun, Oscar Ö, Bico, Besim, Chaudhry, Uzma, Wagner, Henrik, Koul, Sasha, Tydén, Patrik, Scherstén, Fredrik, Jovinge, Stefan, Svensson, Peter J, Gustav Smith, J, van der Pals, Jesper

“…Abstract Introduction Treatment with warfarin in combination with clopidogrel has been shown to reduce the incidence of major bleeding as compared to triple…”
Get full text

Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: A multi-centre efficacy study using the Reitan Catheter Pump (RCP) by Keeble, Thomas R., Karamasis, Grigoris V., Rothman, Martin T., Ricksten, Sven-Erik, Ferrari, Markus, Hullin, Roger, Scherstén, Fredrik, Reitan, Oyvind, Kirking, Sebastian T., Cleland, John G.F., Smith, Elliot J.

“…Worsening heart failure complicated by congestion, hypotension, and renal dysfunction is difficult to manage, increasingly common and predicts a poor outcome…”
Get full text

Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts by Fröbert, Ole, MD, PhD, Scherstén, Fredrik, MD, PhD, James, Stefan K., MD, PhD, Carlsson, Jörg, MD, PhD, Lagerqvist, Bo, MD, PhD

“…Background Long-term safety and efficacy data of drug-eluting stents (DESs) in saphenous vein grafts (SVGs) are lacking. This study sought to compare the…”
Get full text

Delay From First Medical Contact to Primary PCI and All‐Cause Mortality: A Nationwide Study of Patients With ST‐Elevation Myocardial Infarction by Koul, Sasha, Andell, Pontus, Martinsson, Andreas, Gustav Smith, J., Pals, Jesper, Scherstén, Fredrik, Jernberg, Tomas, Lagerqvist, Bo, Erlinge, David

“…Background Early reperfusion in the setting of an ST‐elevation myocardial infarction (STEMI) is of utmost importance. However, the effects of early versus late…”
Get full text

Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) by Stenestrand, Ulf, James, Stefan K., Lindbäck, Johan, Fröbert, Ole, Carlsson, Jörg, Scherstén, Fredrik, Nilsson, Tage, Lagerqvist, Bo

“…Aims Patients with diabetes mellitus have more extensive coronary artery disease, more disease progression, and restenosis. The use of drug-eluting stents…”
Get full text

Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria by Carlsson, Jörg, MD, PhD, James, Stefan K., MD, PhD, Lindbäck, Johan, PhD, Scherstén, Fredrik, MD, PhD, Nilsson, Tage, MD, PhD, Stenestrand, Ulf, MD, PhD, Lagerqvist, Bo, MD, PhD

“…Objectives The aim of this study was to investigate the outcome of bare-metal stents (BMS) versus drug-eluting stents (DES) after on-label as well as off-label…”
Get full text

Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants by van der Pals, Jesper, Holmqvist, Fredrik, Borgquist, Rasmus, Götberg, Matthias, Nseir, Mohaned, Koul, Sasha, Isma, Nazim, Scherstén, Fredrik, Tydén, Patrik, Braun, Oscar Ö., Erlinge, David

“…Optimal antithrombotic treatment after an acute coronary syndrome (ACS) in patients with atrial fibrillation is unclear. Data on outcomes in patients on…”
Get full text

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction by Erlinge, David, Koul, Sasha, Omerovic, Elmir, Fröbert, Ole, Linder, Rikard, Danielewicz, Mikael, Hamid, Mehmet, Venetsanos, Dimitrios, Henareh, Loghman, Pettersson, Björn, Wagner, Henrik, Grimfjärd, Per, Jensen, Jens, Hofmann, Robin, Ulvenstam, Anders, Völz, Sebastian, Petursson, Petur, Östlund, Ollie, Sarno, Giovanna, Wallentin, Lars, Scherstén, Fredrik, Eriksson, Peter, James, Stefan

“…Background: The optimal anti-coagulation strategy for patients with non-ST-elevation myocardial infarction treated with percutaneous coronary intervention is…”
Get full text

A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI by Koul, Sasha, Andell, Pontus, Martinsson, Andreas, Smith, J Gustav, Scherstén, Fredrik, Harnek, Jan, Götberg, Matthias, Norström, Eva, Björnsson, Sven, Erlinge, David

“…Despite advances in anti-platelet treatments, there still exists an early increase in both ischemic as well as bleeding events following primary PCI in…”
Get full text